why choose us

First received: October 12, 2022

Clinical Trial: CML Pediatric ITK Response According to Molecular Identification at Diagnosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Myeloid Leukemia

Study Type: OBSERVATIONAL


Official Title: CML Pediatric ITK Response According to Molecular Identification at Diagnosis (CML Piramid

Brief Summary: Treatment of chronic myeloid leukemia (CML) has been revolutionized by tyrosine kinase inhibitor (TKI).Nevertheless, case of failure and suboptimal response are still observed even in children.Pediatric CML is a rare disease and differs from adult in terms of disease presentation and treatment response underlying a likely different CML biology.Molecular mechanisms that induce resistance to TKI are still poorly characterized except mutations in the tyrosine kinase domain of BCR::ABL1.We propose to search for a…

Read more